期刊
CELL CHEMICAL BIOLOGY
卷 29, 期 5, 页码 799-+出版社
CELL PRESS
DOI: 10.1016/j.chembiol.2021.07.022
关键词
-
资金
- JSPS KAKENHI [JP17H05070, JP21H02746, JP17K00848, JP20K02383]
- AMED [JP21fk0210062]
- NIH [R01-AI095690]
This study identified FADS2 as a key determinant of cellular sensitivity to ferroptosis. Inhibiting FADS2 enhances HCV replication significantly, while the ferroptosis-inducing compound erastin alters the conformation of HCV replicase, making it more sensitive to direct-acting antiviral agents targeting the viral protease.
The metabolic oxidative degradation of cellular lipids severely restricts replication of hepatitis C virus (HCV), a leading cause of chronic liver disease, but little is known about the factors regulating this process in infected cells. Here we show that HCV is restricted by an iron-dependent mechanism resembling the one triggering ferroptosis, an iron-dependent form of non-apoptotic cell death, and mediated by the non-canonical desaturation of oleate to Mead acid and other highly unsaturated fatty acids by fatty acid desaturase 2 (FADS2). Genetic depletion and ectopic expression experiments show FADS2 is a key determinant of cellular sensitivity to ferroptosis. Inhibiting FADS2 markedly enhances HCV replication, whereas the ferroptosisinducing compound erastin alters conformation of the HCV replicase and sensitizes it to direct-acting antiviral agents targeting the viral protease. Our results identify FADS2 as a rate-limiting factor in ferroptosis, and suggest the possibility of pharmacologically manipulating the ferroptosis pathway to attenuate viral replication.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据